AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 86 filers reported holding AKCEA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $207,000 | -67.4% | 11,400 | -75.4% | 0.00% | – |
Q2 2020 | $634,000 | -47.5% | 46,300 | -45.2% | 0.00% | – |
Q1 2020 | $1,207,000 | -48.8% | 84,430 | -39.4% | 0.00% | – |
Q4 2019 | $2,359,000 | -49.8% | 139,294 | -54.4% | 0.00% | -100.0% |
Q3 2019 | $4,697,000 | -77.8% | 305,200 | -66.2% | 0.00% | -33.3% |
Q2 2019 | $21,176,000 | +136.0% | 903,042 | +185.1% | 0.00% | 0.0% |
Q1 2019 | $8,972,000 | +31.3% | 316,700 | +39.7% | 0.00% | +50.0% |
Q4 2018 | $6,833,000 | -11.9% | 226,700 | +2.3% | 0.00% | 0.0% |
Q3 2018 | $7,760,000 | +443.8% | 221,600 | +268.1% | 0.00% | – |
Q2 2018 | $1,427,000 | +21.1% | 60,200 | +30.9% | 0.00% | – |
Q1 2018 | $1,178,000 | – | 46,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iguana Healthcare Management, LLC | 100,000 | $1,736,000 | 1.13% |
BB BIOTECH AG | 1,248,650 | $21,677,000 | 0.61% |
Virtus ETF Advisers LLC | 18,071 | $314,000 | 0.39% |
Eventide Asset Management | 420,000 | $7,291,000 | 0.38% |
Granahan Investment Management | 194,376 | $3,374,000 | 0.26% |
ALTRINSIC GLOBAL ADVISORS LLC | 150,000 | $2,604,000 | 0.10% |
Candriam S.C.A. | 114,571 | $1,990,000 | 0.03% |
ARDSLEY ADVISORY PARTNERS LP | 15,000 | $260,000 | 0.03% |
Delpha Capital Management, LLC | 1,521 | $26,000 | 0.03% |
FMR LLC | 9,981,244 | $173,274,000 | 0.02% |